Skip to content

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Pim A.L. Tonino, Bernard De Bruyne, Nico H.J. Pijls, Uwe Siebert, Fumiaki Ikeno, Marcel van ’t Veer, Volker Klauß, Ganesh Manoharan, Thomas Engstrøm, Keith G. Oldroyd, Peter N Ver Lee, Philip A. MacCarthy, William Fuller Fearon

New England Journal of Medicine · 2009 · 4,305 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Tonino, P. A., Bruyne, B. D., Pijls, N. H., Siebert, U., Ikeno, F., Veer, M. van ’t, Klauß, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., Lee, P. N. V., MacCarthy, P. A., & Fearon, W. F. (2009). Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New England Journal of Medicine, 360(3), 213–224. https://doi.org/10.1056/nejmoa0807611

In text: (Tonino et al., 2009)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

BACKGROUND: In patients with multivessel coronary artery disease who are undergoing percutaneous coronary intervention (PCI), coronary angiography is the standard method for guiding the placement of the stent. It is unclear whether routine measurement of fractional flow reserve (FFR; the ratio of maximal blood flow in a stenotic artery to normal maximal flow), in addition to angiography, improves outcomes. METHODS: In 20 medical centers in the United States and Europe, we randomly assigned 1005 patients with multivessel coronary artery disease to undergo PCI with implantation of drug-eluting stents guided by angiography alone or guided by FFR measurements in addition to angiography. Before randomization, lesions requiring PCI were identified on the basis of their angiographic appearance. Patients assigned to angiography-guided PCI underwent stenting of all indicated lesions, whereas those assigned to FFR-guided PCI underwent stenting of indicated lesions only if the FFR was 0.80 or less. The primary end point was the rate of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. RESULTS: The mean (+/-SD) number of indicated lesions per patient was 2.7+/-0.9 in the angiography group and 2.8+/-1.0 in the FFR group (P=0.34). The number of stents used per patient was 2.7+/-1.2 and 1.9+/-1.3, respectively (P<0.001). The 1-year event rate was 18.3% (91 patients) in the angiography group and 13.2% (67 patients) in the FFR group (P=0.02). Seventy-eight percent of the patients in the angiography group were free from angina at 1 year, as compared with 81% of patients in the FFR group (P=0.20). CONCLUSIONS: Routine measurement of FFR in patients with multivessel coronary artery disease who are undergoing PCI with drug-eluting stents significantly reduces the rate of the composite end point of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. (ClinicalTrials.gov number, NCT00267774.)

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study2004
  2. Tissue Plasminogen Activator for Acute Ischemic Stroke1995
  3. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation2017
  4. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association2019
  5. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.1986

Metadata from OpenAlex (CC0). Citations are generated from the published record.